Articles by Anurag S. Rathore - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Anurag S. Rathore

Evolution of the Monoclonal Antibody Purification Platform

The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
Nov 1, 2013

The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.

Regulatory Challenges in the QbD Paradigm

The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical trends.
Sep 1, 2012

The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical trends.

Tools for Enabling Process Analytical Technology Applications in Biotechnology

The authors review the various analytical methods that can enable use of PAT
Aug 1, 2012

The authors review the various analytical methods that can enable use of PAT.

Key Considerations for Development and Production of Vaccine Products

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
Mar 2, 2012

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.

Development and Commercialization of Biosimilars in India

The author aims to present the current status of India in this context, the challenges that need to be overcome, and some recommendations that may alleviate these challenges.
Nov 1, 2011

The author explains the current status of India, the challenges, and recommendations that may alleviate these challenges.

Operational Excellence: More Data or Smarter Approach?

The authors focus on operational excellence in manufacturing of biotechnology therapeutic products in the QbD paradigm.
Jun 1, 2011

The authors focus on operational excellence in manufacturing of biotechnology therapeutic products in the QbD paradigm.

PDA's New Technical Report for Biotech Cleaning Validation

The authors encourage biotech manufacturers to consult PDA Technical Report No. 49 for a detailed perspective on current practices and issues in biotech cleaning validation.
Mar 1, 2011

The authors encourage biotech manufacturers to consult PDA Technical Report No. 49 for a detailed perspective on current practices and issues in biotech cleaning validation.

Achieving Process Intensification by Scheduling and Debottlenecking Biotech Processes

An approach to reduce batch time, increase productivity, and decrease costs.
Feb 1, 2011

An approach to reduce batch time, increase productivity, and decrease costs.

ADVERTISEMENT

ADVERTISEMENT

Click here